Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
Lee JY, Park SS, Jeon YW, Shin SH, Yahng SA, Min CK; Catholic Research Network for Multiple Myeloma (CAREMM-2102 study). Lee JY, et al. J Cancer Res Clin Oncol. 2023 Oct;149(13):11907-11918. doi: 10.1007/s00432-023-04993-8. Epub 2023 Jul 7. J Cancer Res Clin Oncol. 2023. PMID: 37418057
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001).
Park SS, Shin SH, Lee JY, Jeon YW, Yhang SA, Min CK. Park SS, et al. Among authors: lee jy. Cancers (Basel). 2023 Sep 28;15(19):4783. doi: 10.3390/cancers15194783. Cancers (Basel). 2023. PMID: 37835477 Free PMC article.
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.
Hyun SY, Han SH, Kim SJ, Jang JE, Kim Y, Cho H, Lee JY, Cheong JW, Min YH, Song JW, Kim JS. Hyun SY, et al. Among authors: lee jy. J Korean Med Sci. 2016 Apr;31(4):510-8. doi: 10.3346/jkms.2016.31.4.510. Epub 2016 Feb 22. J Korean Med Sci. 2016. PMID: 27051233 Free PMC article.
High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.
Hwang DY, Kim SJ, Cheong JW, Kim Y, Jang JE, Lee JY, Min YH, Yang WI, Kim JS. Hwang DY, et al. Among authors: lee jy. Leuk Lymphoma. 2016;57(1):51-7. doi: 10.3109/10428194.2015.1041387. Epub 2015 Jun 19. Leuk Lymphoma. 2016. PMID: 25899401
14,237 results
You have reached the last available page of results. Please see the User Guide for more information.